These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27156313)

  • 21. Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study.
    Polito F; Cicciu' M; Aguennouz M; Cucinotta M; Cristani M; Lauritano F; Sindoni A; Gioffre'-Florio M; Fama F
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):504-9. PubMed ID: 27343243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating microRNAs Expressions as Genetic Biomarkers in Pancreatic Cancer Patients Continuous Non-Invasive Monitoring.
    Sandesc M; Dinu A; Rogobete AF; Bedreag OH; Sandesc D; Papurica M; Bratu LM; Negoita S; Vernic C; Popovici SE; Corneci D
    Clin Lab; 2017 Oct; 63(10):1561-1566. PubMed ID: 29035444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress and role of antioxidant supplementation in critical illness.
    Mishra V
    Clin Lab; 2007; 53(3-4):199-209. PubMed ID: 17447658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The prognostic value of serum procalcitonin on severity of illness in non-sepsis critically ill patients].
    Ma J; Wang S; Chen D; Duan J; Li C; Li G
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Aug; 28(8):688-93. PubMed ID: 27434557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Micronutrient Plasma Level Changes Are Related to Oxidative Stress Intensity in Critically Ill Children.
    Valla FV; Bost M; Roche S; Pitance M; Cuerq C; Ridout J; Ecochard R; Ginhoux T; Bellon A; Ford-Chessel C; Portefaix A; Javouhey E; Blond E
    Pediatr Crit Care Med; 2018 Sep; 19(9):e455-e463. PubMed ID: 29923936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The miRNA Mirage: How Close Are We to Finding a Non-Invasive Diagnostic Biomarker in Endometriosis? A Systematic Review.
    Agrawal S; Tapmeier T; Rahmioglu N; Kirtley S; Zondervan K; Becker C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29463003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of miRNAs as biomarkers in sepsis.
    Dumache R; Rogobete AF; Bedreag OH; Sarandan M; Cradigati AC; Papurica M; Dumbuleu CM; Nartita R; Sandesc D
    Anal Cell Pathol (Amst); 2015; 2015():186716. PubMed ID: 26221578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications.
    Tsochandaridis M; Nasca L; Toga C; Levy-Mozziconacci A
    Biomed Res Int; 2015; 2015():294954. PubMed ID: 25699269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating microRNAs as emerging cardiac biomarkers responsive to acute exercise.
    de Gonzalo-Calvo D; Dávalos A; Fernández-Sanjurjo M; Amado-Rodríguez L; Díaz-Coto S; Tomás-Zapico C; Montero A; García-González Á; Llorente-Cortés V; Heras ME; Boraita Pérez A; Díaz-Martínez ÁE; Úbeda N; Iglesias-Gutiérrez E
    Int J Cardiol; 2018 Aug; 264():130-136. PubMed ID: 29776561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of oxidative stress in critically ill patients: what should be measured, when and how?
    Lemineur T; Deby-Dupont G; Preiser JC
    Curr Opin Clin Nutr Metab Care; 2006 Nov; 9(6):704-10. PubMed ID: 17053423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of biomarkers to establish potential role and function of circulating microRNAs in acute heart failure.
    Vegter EL; Schmitter D; Hagemeijer Y; Ovchinnikova ES; van der Harst P; Teerlink JR; O'Connor CM; Metra M; Davison BA; Bloomfield D; Cotter G; Cleland JG; Givertz MM; Ponikowski P; van Veldhuisen DJ; van der Meer P; Berezikov E; Voors AA; Khan MA
    Int J Cardiol; 2016 Dec; 224():231-239. PubMed ID: 27661412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced oxidation protein products (AOPP) for monitoring oxidative stress in critically ill patients: a simple, fast and inexpensive automated technique.
    Selmeci L; Seres L; Antal M; Lukács J; Regöly-Mérei A; Acsády G
    Clin Chem Lab Med; 2005; 43(3):294-7. PubMed ID: 15843234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress status: possible guideline for clinical management of critically ill patients.
    Bela P; Bahl R; Sane AS; Sawant PH; Shah VR; Mishra VV; Trivedi HL
    Panminerva Med; 2001 Mar; 43(1):27-31. PubMed ID: 11319515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyridoxal-5'-phosphate deficiency is associated with hyperhomocysteinemia regardless of antioxidant, thiamine, riboflavin, cobalamine, and folate status in critically ill patients.
    Molina-López J; Florea D; Quintero-Osso B; de la Cruz AP; Rodríguez-Elvira M; Del Pozo EP
    Clin Nutr; 2016 Jun; 35(3):706-12. PubMed ID: 26071632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress.
    Ali Sheikh MS; Salma U; Zhang B; Chen J; Zhuang J; Ping Z
    Oxid Med Cell Longev; 2016; 2016():5893064. PubMed ID: 27379177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From Oxidative Stress Damage to Pathways, Networks, and Autophagy via MicroRNAs.
    Engedal N; Žerovnik E; Rudov A; Galli F; Olivieri F; Procopio AD; Rippo MR; Monsurrò V; Betti M; Albertini MC
    Oxid Med Cell Longev; 2018; 2018():4968321. PubMed ID: 29849898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
    Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
    Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating microRNAs: The Future of Biomarkers in Anti-doping Field.
    Leuenberger N; Saugy M
    Adv Exp Med Biol; 2015; 888():401-8. PubMed ID: 26663194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating levels of miR-150 are associated with poorer outcomes of A/H1N1 infection.
    Morán J; Ramírez-Martínez G; Jiménez-Alvarez L; Cruz A; Pérez-Patrigeon S; Hidalgo A; Orozco L; Martínez A; Padilla-Noriega L; Avila-Moreno F; Cabello C; Granados J; Ortíz-Quintero B; Ramírez-Venegas A; Ruíz-Palacios GM; Zlotnik A; Merino E; Zúñiga J
    Exp Mol Pathol; 2015 Oct; 99(2):253-61. PubMed ID: 26148929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating miRNAs: a new generation of anti-doping biomarkers.
    Leuenberger N; Robinson N; Saugy M
    Anal Bioanal Chem; 2013 Dec; 405(30):9617-23. PubMed ID: 24077830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.